Efficacy and safety of letosteine in the treatment of sputum thickening and expectoration difficulty in patients with respiratory diseases: a multicenter, randomized, double-masked, double dummy, positive drug parallel controlled trial

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.69, Iss.11, 2014-11, pp. : 842-849

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Besifloxacin Ophthalmic Suspension 0.6% in Children and Adolescents with Bacterial Conjunctivitis: A Post Hoc, Subgroup Analysis of Three Randomized, Double-Masked, Parallel-Group, Multicenter Clinical Trials

By Comstock Timothy L.  

Pediatric Drugs, Vol. 12, Iss. 2, 2010-04 ,pp. : 105-112

Adis International

Access to resources Recommend Favorite

Efficacy of a Non-Hormonal Treatment, BRN-01, on Menopausal Hot Flashes: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

By Colau Jean-Claude  

Drugs in R&D, Vol. 12, Iss. 3, 2012-09 ,pp. : 107-119

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Celecoxib versus Naproxen in Patients with Osteoarthritis of the Knee: a Randomized, Double-blind, Double-dummy Trial

By Essex MN   Bhadra P   Sands GH  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1357-1370

Field House Publishing

Access to resources Recommend Favorite

Efficacy and Safety of Adjunctive Zonisamide in Adult Patients with Refractory Partial-Onset Epilepsy: A Randomized, Double-Blind, Placebo-Controlled Trial

By Lu Yang   Xiao Zhanqin  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 221-229

Adis International

Access to resources Recommend Favorite

Zaltoprofen, a noninferior alternative to diclofenac for the treatment of primary knee osteoarthritis –– a comparative evaluation of efficacy and safety in a 4-week, multicentric, randomized, double-blind, double-dummy trial

By Pareek Anil   Gupta Anil K   Chandurkar Nitin B   Sirsikar Ashish D   Ambade Ratnakar E   Jesalpura Bhavesh H   Swamy Amit P  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1007-1015

Informa Healthcare

Access to resources Recommend Favorite